메뉴 건너뛰기
The Lancet
Volumn 372, Issue 9634, 2008, Pages 188-189
Ethnicity and breast cancer research
Author keywords

[No Author keywords available]
Indexed keywords

CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GEFITINIB; LAPATINIB; PACLITAXEL; TRASTUZUMAB;
EID: 47149115566     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61052-1     Document Type: Note
Times cited : (5)
References (11)
  • 1
    • 39749154793 scopus 로고    scopus 로고
    • Curado M., Edwards B., Shin H., et al. (Eds), International Agency for Research on Cancer, Lyon, France
    • In: Curado M., Edwards B., Shin H., et al. (Eds). Cancer incidence in five continents Vol. IX (2007), International Agency for Research on Cancer, Lyon, France
    • (2007) Cancer incidence in five continents , vol.IX
  • 2
    • 33744960226 scopus 로고    scopus 로고
    • Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
    • Carey L., Perou C., Livasy C., et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295 (2006) 2492-2502
    • (2006) JAMA , vol.295 , pp. 2492-2502
    • Carey, L.1    Perou, C.2    Livasy, C.3
  • 3
    • 34548770702 scopus 로고    scopus 로고
    • Within-stage racial differences in tumour size and number of positive lymph nodes in women with breast cancer
    • McBride R., Hershman D., Tsai W.-Y., et al. Within-stage racial differences in tumour size and number of positive lymph nodes in women with breast cancer. Cancer 110 (2007) 1201-1208
    • (2007) Cancer , vol.110 , pp. 1201-1208
    • McBride, R.1    Hershman, D.2    Tsai, W.-Y.3
  • 4
    • 0017362350 scopus 로고
    • Differences in breast cancer between Japan and the United States
    • Nemoto T., Tominaga T., Chamberlain A., et al. Differences in breast cancer between Japan and the United States. J Natl Cancer Inst 58 (1977) 193-197
    • (1977) J Natl Cancer Inst , vol.58 , pp. 193-197
    • Nemoto, T.1    Tominaga, T.2    Chamberlain, A.3
  • 5
    • 47149101483 scopus 로고    scopus 로고
    • Buchana D, Coates A, Piccart M, et al. International challenges in breast cancer as perceived by leaders in medicine, public policy and advocacy. National Consortium of Breast Centers meeting, Las Vegas, NV, USA; March 2, 2008.
    • Buchana D, Coates A, Piccart M, et al. International challenges in breast cancer as perceived by leaders in medicine, public policy and advocacy. National Consortium of Breast Centers meeting, Las Vegas, NV, USA; March 2, 2008.
  • 6
    • 42949157368 scopus 로고    scopus 로고
    • Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer
    • Musolino A., Naldi N., Bortesi B., et al. Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer. J Clin Oncol 26 (2008) 1789-1796
    • (2008) J Clin Oncol , vol.26 , pp. 1789-1796
    • Musolino, A.1    Naldi, N.2    Bortesi, B.3
  • 7
    • 0032779054 scopus 로고    scopus 로고
    • Variant genotypes of the low-affinity Fcγ receptors in two control populations and a review of low-affinity Fcγ receptor polymorphisms in control and disease populations
    • Lehrnbecher T., Foster C., Zhu S., et al. Variant genotypes of the low-affinity Fcγ receptors in two control populations and a review of low-affinity Fcγ receptor polymorphisms in control and disease populations. Blood 94 (1999) 4220-4232
    • (1999) Blood , vol.94 , pp. 4220-4232
    • Lehrnbecher, T.1    Foster, C.2    Zhu, S.3
  • 8
    • 34548509226 scopus 로고    scopus 로고
    • FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor-receptor expressing metastatic breast cancer patients treated with single agent cetuximab
    • Zhang W., Gordon M., Schultheis A., et al. FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor-receptor expressing metastatic breast cancer patients treated with single agent cetuximab. J Clin Oncol 25 (2007) 3712-3718
    • (2007) J Clin Oncol , vol.25 , pp. 3712-3718
    • Zhang, W.1    Gordon, M.2    Schultheis, A.3
  • 9
    • 28844501639 scopus 로고    scopus 로고
    • Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers
    • Shigematsu H., and Gazdar A. Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers. Int J Cancer 118 (2006) 257-262
    • (2006) Int J Cancer , vol.118 , pp. 257-262
    • Shigematsu, H.1    Gazdar, A.2
  • 10
    • 0037431759 scopus 로고    scopus 로고
    • Severe acute interstitial pneumonia and gefitinib
    • Inoue A., Saijo Y., Maemondo M., et al. Severe acute interstitial pneumonia and gefitinib. Lancet 361 (2003) 137-139
    • (2003) Lancet , vol.361 , pp. 137-139
    • Inoue, A.1    Saijo, Y.2    Maemondo, M.3
  • 11
    • 33845886440 scopus 로고    scopus 로고
    • Lapatinib plus capecitabine for HER2-positive advanced breast cancer
    • Geyer C., Forster J., Lindquist D., et al. Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J Med 355 (2006) 2733-2743
    • (2006) N Engl J Med , vol.355 , pp. 2733-2743
    • Geyer, C.1    Forster, J.2    Lindquist, D.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.